MRK Net income
Net income at Merck & Co. rose to $18.3B in fiscal 2025, the highest in the 5 years reported, from $17.1B in 2024.
Net income attributable to the parent / common stockholders, as filed.
SOURCE: us-gaap:NetIncomeLoss · EDGAR CompanyFacts · CIK 310158 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Net income | Change |
|---|---|---|
| FY2025 | $18.3B | +$1.1B |
| FY2024 | $17.1B | +$16.8B |
| FY2023 | $365M | $-14.2B |
| FY2022 | $14.5B | +$1.5B |
| FY2021 | $13.0B | — |
Cross-checks touching this measure FROM THE FILING REVIEW
◐ PARTLYnet income growth
3 of 4 quoted figures reconcile ($ 18,254 against net income attributable to common; $ 17,117 against net income attributable to common; 7 % against net income attributable to common); 9 % does not map to a filed line on this page — carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →◐ WATCHCash conversion stability
The ratio of operating cash flow to net income swings 33.60× across three years. Net income sits near zero in at least one year, so the ratio is an arithmetic artefact of a small denominator more than a cash story.
FY2025 10-K · FULL RECONCILIATION →More SAME DATA, OTHER VIEWS
Net income across coverage → · MRK company view →
Revenue · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.